{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:02:55Z","timestamp":1790488975264,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40263-018-0535-3","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T12:19:11Z","timestamp":1529497151000},"page":"485-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["A Systematic Review and Meta-Analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-9634","authenticated-orcid":false,"given":"Ross","family":"Penninkilampi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy D.","family":"Eslick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"key":"535_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/01.STR.0000199613.38911.b2","volume":"37","author":"S Seshadri","year":"2006","unstructured":"Seshadri S, Beiser A, Kelly-Hayes M, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke. 2006;37:345\u201350.","journal-title":"Stroke"},{"issue":"13","key":"535_CR2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","volume":"2017","author":"Alzheimer\u2019s Association","year":"2017","unstructured":"Alzheimer\u2019s Association. Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2017;2017(13):325\u201373.","journal-title":"Alzheimers Dement"},{"key":"535_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","volume":"13","author":"A Wimo","year":"2017","unstructured":"Wimo A, Guerchet M, Ali GC, et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement. 2017;13:1\u20137.","journal-title":"Alzheimers Dement."},{"key":"535_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/joim.12178","volume":"275","author":"A Solomon","year":"2014","unstructured":"Solomon A, Mangialasche F, Richard E, et al. Advances in the prevention of Alzheimer\u2019s disease and dementia. J Intern Med. 2014;275:229\u201350.","journal-title":"J Intern Med"},{"key":"535_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1517\/14740338.2015.1014796","volume":"14","author":"S Billioti de Gage","year":"2015","unstructured":"Billioti de Gage S, Pariente A, Begaud B. Is there really a link between benzodiazepine use and the risk of dementia? Expert Opin Drug Saf. 2015;14:733\u201347.","journal-title":"Expert Opin Drug Saf."},{"key":"535_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S0033291704003897","volume":"35","author":"H Verdoux","year":"2005","unstructured":"Verdoux H, Lagnaoui R, Begaud B. Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med. 2005;35:307\u201315.","journal-title":"Psychol Med"},{"key":"535_CR7","doi-asserted-by":"publisher","first-page":"e0127836","DOI":"10.1371\/journal.pone.0127836","volume":"10","author":"G Zhong","year":"2015","unstructured":"Zhong G, Wang Y, Zhang Y, Zhao Y. Association between benzodiazepine use and dementia: a meta-analysis. PLoS One. 2015;10:e0127836.","journal-title":"PLoS One"},{"key":"535_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry. 2015;72:136\u201342.","journal-title":"JAMA Psychiatry"},{"key":"535_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00002093-199803000-00002","volume":"12","author":"J Fastbom","year":"1998","unstructured":"Fastbom J, Forsell Y, Winblad B. Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Dis Assoc Disord. 1998;12:14\u20137.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"535_CR10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0895-4356(01)00453-X","volume":"55","author":"R Lagnaoui","year":"2002","unstructured":"Lagnaoui R, B\u00e9gaud B, Moore N, et al. Benzodiazepine use and risk of dementia: a nested case-control study. J Clin Epidemiol. 2002;55:314\u20138.","journal-title":"J Clin Epidemiol"},{"key":"535_CR11","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/JGP.0b013e3181a65210","volume":"17","author":"C-S Wu","year":"2009","unstructured":"Wu C-S, Wang S-C, Chang I-S, Lin K-M. The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data. Am J Geriatr Psychiatry. 2009;17:614\u201320.","journal-title":"Am J Geriatr Psychiatry."},{"key":"535_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/JGP.0b013e3181e049ca","volume":"19","author":"CS Wu","year":"2011","unstructured":"Wu CS, Ting TT, Wang SC, Chang IS, Lin KM. Effect of benzodiazepine discontinuation on dementia risk. Am J Geriatr Psychiatry. 2011;19:151\u20139.","journal-title":"Am J Geriatr Psychiatry."},{"key":"535_CR13","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s40264-015-0319-3","volume":"38","author":"P Imfeld","year":"2015","unstructured":"Imfeld P, Bodmer M, Jick SS, Meier CR. Benzodiazepine use and risk of developing Alzheimer\u2019s disease or vascular dementia: a case-control analysis. Drug Saf. 2015;38:909\u201319.","journal-title":"Drug Saf"},{"key":"535_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.03.003","volume":"78","author":"A Arf\u00e8","year":"2016","unstructured":"Arf\u00e8 A, Corrao G. The lag-time approach improved drug\u2013outcome association estimates in presence of protopathic bias. J Clin Epidemiol. 2016;78:101\u20137.","journal-title":"J Clin Epidemiol"},{"key":"535_CR15","doi-asserted-by":"publisher","first-page":"g5205","DOI":"10.1136\/bmj.g5205","volume":"349","author":"S Billioti de Gage","year":"2014","unstructured":"Billioti de Gage S, Moride Y, Ducruet T, et al. Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study. BMJ. 2014;349:g5205.","journal-title":"BMJ"},{"key":"535_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/jech-2011-200314","volume":"66","author":"J Gallacher","year":"2012","unstructured":"Gallacher J, Elwood P, Pickering J, Bayer A, Fish M, Ben-Shlomo Y. Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS). J Epidemiol Community Health. 2012;66:869\u201373.","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"535_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3233\/JAD-151006","volume":"54","author":"W Gomm","year":"2016","unstructured":"Gomm W, von Holt K, Thome F, et al. Regular benzodiazepine and z-substance use and risk of dementia: an analysis of German claims data. J Alzheimers Dis. 2016;54(2):801\u20138.","journal-title":"J Alzheimers Dis."},{"key":"535_CR18","doi-asserted-by":"publisher","first-page":"i90","DOI":"10.1136\/bmj.i90","volume":"352","author":"SL Gray","year":"2016","unstructured":"Gray SL, Dublin S, Yu O, et al. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ. 2016;352:i90.","journal-title":"BMJ"},{"key":"535_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40263-016-0404-x","volume":"31","author":"FA Bietry","year":"2017","unstructured":"Bietry FA, Pfeil AM, Reich O, Schwenkglenks M, Meier CR. Benzodiazepine use and risk of developing Alzheimer\u2019s disease: a case-control study bassed on Swiss claims data. CNS Drugs. 2017;31:245\u201351.","journal-title":"CNS Drugs"},{"key":"535_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","volume":"12","author":"D Shash","year":"2016","unstructured":"Shash D, Kurth T, Bertrand M, et al. Benzodiazepine, psychotropic medication, and dementia: a population-based cohort study. Alzheimers Dement. 2016;12:604\u201313.","journal-title":"Alzheimers Dement."},{"issue":"5","key":"535_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/psyg.12239","volume":"17","author":"TT Chan","year":"2017","unstructured":"Chan TT, Leung WC, Li V, et al. Association between high cumulative dose of benzodiazepine in Chinese patients and risk of dementia: a preliminary retrospective case-control study. Psychogeriatrics. 2017;17(5):310\u20136.","journal-title":"Psychogeriatrics."},{"key":"535_CR22","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/jgs.14756","volume":"65","author":"F Mawanda","year":"2017","unstructured":"Mawanda F, Wallace RB, McCoy K, Abrams TE. PTSD, psychotropic medication use, and the risk of dementia among US veterans: a retrospective cohort study. J Am Geriatr Soc. 2017;65:1043\u201350.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"535_CR23","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jalz.2017.04.010","volume":"13","author":"AM Tolppanen","year":"2017","unstructured":"Tolppanen AM, Taipale H, Hartikainen S. Head or brain injuries and Alzheimer\u2019s disease: a nested case-control register study. Alzheimers Dement. 2017;13(12):1371\u20139.","journal-title":"Alzheimers Dement."},{"key":"535_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000454881","volume":"47","author":"MM Islam","year":"2016","unstructured":"Islam MM, Iqbal U, Walther B, et al. Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology. 2016;47:181\u201391.","journal-title":"Neuroepidemiology."},{"key":"535_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Group P. Altman DG Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336\u201341.","journal-title":"Int J Surg."},{"key":"535_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"535_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"535_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"535_CR29","first-page":"157","volume":"8","author":"RG Orwin","year":"1983","unstructured":"Orwin RG. A fail-safe N for effect size in meta-analysis. J Edu Stat. 1983;8:157\u20139.","journal-title":"J Edu Stat"},{"key":"535_CR30","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2009. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp . Accessed 11 Jan 2017."},{"key":"535_CR31","doi-asserted-by":"publisher","first-page":"e49113","DOI":"10.1371\/journal.pone.0049113","volume":"7","author":"PL Chen","year":"2012","unstructured":"Chen PL, Lee WJ, Sun WZ, Oyang YJ, Fuh JL. Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study. PLoS One. 2012;7:e49113.","journal-title":"PLoS One"},{"key":"535_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1471-2369-13-129","volume":"13","author":"K-C Cheng","year":"2012","unstructured":"Cheng K-C, Chen Y-L, Lai S-W, Mou C-H, Tsai P-Y, Sung F-C. Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan. BMC Nephrol. 2012;13:129.","journal-title":"BMC Nephrol"},{"key":"535_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jamda.2014.02.009","volume":"15","author":"FY Hsiao","year":"2014","unstructured":"Hsiao FY, Peng LN, Lin MH, Chen LK. Dose-responsive effect of psychotropic drug use and subsequent dementia: a nationwide propensity score matched case-control study in Taiwan. J Am Med Dir Assoc. 2014;15:509\u201313.","journal-title":"J Am Med Dir Assoc."},{"key":"535_CR34","doi-asserted-by":"publisher","first-page":"e809","DOI":"10.1097\/MD.0000000000000809","volume":"94","author":"HI Shih","year":"2015","unstructured":"Shih HI, Lin CC, Tu YF, et al. An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study. Medicine (Baltimore). 2015;94:e809.","journal-title":"Medicine (Baltimore)."},{"key":"535_CR35","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.euroneuro.2015.09.011","volume":"25","author":"HY Chiu","year":"2015","unstructured":"Chiu HY, Lin EY, Wei L, et al. Hypnotics use but not insomnia increased the risk of dementia in traumatic brain injury patients. Eur Neuropsychopharmacol. 2015;25:2271\u20137.","journal-title":"Eur Neuropsychopharmacol"},{"key":"535_CR36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/ageing\/afn277","volume":"38","author":"R Lagnaoui","year":"2009","unstructured":"Lagnaoui R, Tournier M, Moride Y, et al. The risk of cognitive impairment in older community-dwelling women after benzodiazepine use. Age Ageing. 2009;38:226\u20138.","journal-title":"Age Ageing"},{"key":"535_CR37","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3233\/JAD-150630","volume":"49","author":"L Saarelainen","year":"2016","unstructured":"Saarelainen L, Taipale H, Koponen M, et al. The incidence of benzodiazepine and related drug use in persons with and without Alzheimer\u2019s disease. J Alzheimers Dis. 2016;49:809\u201318.","journal-title":"J Alzheimers Dis."},{"key":"535_CR38","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7150\/ijms.16185","volume":"13","author":"M Takada","year":"2016","unstructured":"Takada M, Fujimoto M, Hosomi K. Association between benzodiazepine use and dementia: data mining of different medical databases. Int J Med Sci. 2016;13:825\u201334.","journal-title":"Int J Med Sci."},{"key":"535_CR39","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1111\/jgs.14378","volume":"64","author":"JE Brodrick","year":"2016","unstructured":"Brodrick JE, Mathys ML. Antidepressant exposure and risk of dementia in older adults with major depressive disorder. J Am Geriatr Soc. 2016;64:2517\u201321.","journal-title":"J Am Geriatr Soc"},{"key":"535_CR40","doi-asserted-by":"publisher","first-page":"e6231","DOI":"10.1136\/bmj.e6231","volume":"345","author":"S Billioti de Gage","year":"2012","unstructured":"Billioti de Gage S, Begaud B, Bazin F, et al. Benzodiazepine use and risk of dementia: prospective population based study. BMJ. 2012;345:e6231.","journal-title":"BMJ"},{"key":"535_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0006-3223(96)00517-3","volume":"41","author":"B Kirkpatrick","year":"1997","unstructured":"Kirkpatrick B, Ross DE. The trap of protopathic bias in neuropsychiatric research. Biol Psychiatry. 1997;41:257\u20138.","journal-title":"Biol Psychiatry"},{"key":"535_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0002-9343(80)90363-0","volume":"68","author":"RI Horwitz","year":"1980","unstructured":"Horwitz RI, Feinstein AR. The problem of \u201cprotopathic bias\u201d in case-control studies. Am J Med. 1980;68:255\u20138.","journal-title":"Am J Med"},{"key":"535_CR43","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/ana.21509","volume":"64","author":"H Amieva","year":"2008","unstructured":"Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer\u2019s disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64:492\u20138.","journal-title":"Ann Neurol"},{"key":"535_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.maturitas.2014.05.009","volume":"79","author":"S Bennett","year":"2014","unstructured":"Bennett S, Thomas AJ. Depression and dementia: cause, consequence or coincidence? Maturitas. 2014;79:184\u201390.","journal-title":"Maturitas."},{"key":"535_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","volume":"7","author":"AL Byers","year":"2011","unstructured":"Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7:323\u201331.","journal-title":"Nat Rev Neurol."},{"key":"535_CR46","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1001\/jama.288.12.1475","volume":"288","author":"CG Lyketsos","year":"2002","unstructured":"Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the Cardiovascular Health Study. JAMA. 2002;288:1475\u201383.","journal-title":"JAMA"},{"key":"535_CR47","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/gps.2509","volume":"26","author":"D Gallagher","year":"2011","unstructured":"Gallagher D, Coen R, Kilroy D, et al. Anxiety and behavioural disturbance as markers of prodromal Alzheimer\u2019s disease in patients with mild cognitive impairment. Int J Geriatr Psychiatry. 2011;26:166\u201372.","journal-title":"Int J Geriatr Psychiatry."},{"key":"535_CR48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00004714-200206000-00009","volume":"22","author":"S Paterniti","year":"2002","unstructured":"Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol. 2002;22:285\u201393.","journal-title":"J Clin Psychopharmacol"},{"key":"535_CR49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00004714-200002000-00002","volume":"20","author":"UE Busto","year":"2000","unstructured":"Busto UE, Bremner KE, Knight KPT, terBrugge K, Sellers EM. Long-term benzodiazepine therapy does not result in brain abnormalities. J Clin Psychopharmacol. 2000;20:2\u20136.","journal-title":"J Clin Psychopharmacol"},{"key":"535_CR50","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1017\/S1355617702813248","volume":"8","author":"Y Stern","year":"2002","unstructured":"Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8:448\u201360.","journal-title":"J Int Neuropsychol Soc"},{"key":"535_CR51","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern Y. Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol. 2012;11:1006\u201312.","journal-title":"Lancet Neurol."},{"key":"535_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11920-016-0727-9","volume":"18","author":"G Airagnes","year":"2016","unstructured":"Airagnes G, Pelissolo A, Lavallee M, Flament M, Limosin F. Benzodiazepine misuse in the elderly: risk factors, consequences, and management. Curr Psychiatry Rep. 2016;18:89.","journal-title":"Curr Psychiatry Rep."},{"key":"535_CR53","doi-asserted-by":"crossref","unstructured":"Dell\u2019osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. Eur Psychiatry. 2013;28:7\u201320.","DOI":"10.1016\/j.eurpsy.2011.11.003"},{"key":"535_CR54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","volume":"18","author":"MJ Barker","year":"2004","unstructured":"Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long-term benzodiazepine use. CNS Drugs. 2004;18:37\u201348.","journal-title":"CNS Drugs"},{"key":"535_CR55","first-page":"2121","volume":"61","author":"LP Longo","year":"2000","unstructured":"Longo LP, Johnson B. Addiction: part I. Benzodiazepines-side effects, abuse risk and alternatives. Am Fam Phys. 2000;61:2121\u20138.","journal-title":"Am Fam Phys"},{"key":"535_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.drugalcdep.2004.09.001","volume":"78","author":"WJ Gorgels","year":"2005","unstructured":"Gorgels WJ, Oude Voshaar RC, Mol AJ, et al. Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug Alcohol Depend. 2005;78:49\u201356.","journal-title":"Drug Alcohol Depend"},{"key":"535_CR57","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2165\/11318890-000000000-00000","volume":"26","author":"S Kaur","year":"2009","unstructured":"Kaur S, Mitchell G, Vitetta L, Roberts MS. Interventions that can reduce inappropriate prescribing in the elderly. Drugs Aging. 2009;26:1013\u201328.","journal-title":"Drugs Aging"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-018-0535-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0535-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0535-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:56:24Z","timestamp":1661475384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-018-0535-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1007\/s40263-018-0535-3","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"20 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"A Summer Research Scholarship provided by the University of Sydney funded the costs of retrieving the medical records for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Ross Penninkilampi and Guy D. Eslick have no potential conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}